Skip to main content
. 2023;24(5):1611–1619. doi: 10.31557/APJCP.2023.24.5.1611

Table 5.

Association between p21 codon 31 of exon 2, exon3 Genotypes and Clinicopathologic Characteristics among Breast Cancer Cases

Variables Total (n) p21 codon -31 (Genotypes) p21 exon-3 (Genotypes)
Ser/Ser Ser/Arg Arg/Arg Χ2 CC C/A AA Χ2
(287) (95) (18) (p value) (279) (114) (7) (p value)
Age group (yrs)
≤40 78 54 (18.82) 22 (23.16) 2 (11.11) 1.238 53 (19.00) 25 (21.93) 0 2.16
>40 322 233 (81.18) 73 (76.84) 16 (88.89) 0.53 226 (81.00) 89 (78.07) 7 (100.0) 0.33
ER status
Positive 218 158 (55.05) 52 (54.74) 8 (44.44) 0.154 154 (55.20) 61 (53.51) 3 (42.86) 0.66
Negative 182 129 (44.95) 43 (45.26) 10 (55.56) 0.92 125 (44.80) 53 (46.49) 4 (57.14) 0.71
PR status
Positive 197 141 (49.13) 47 (49.47) 9 (50.00) 0.002 141 (50.54) 53 (46.49) 3 (42.86) 0.75
Negative 203 146 (50.87) 48 (50.53) 9 (50.00) 0.99 138 (49.46) 61 (53.51) 4 (57.14) 0.68
Her2-neu status
Positive 57 41 (14.29) 14 (14.74) 2 (11.11) 0.115 204 (73.11) 13 (11.40) 1 (14.29) 0.74
Negative 343 246 (85.71) 81 (85.26) 16 (88.89) 0.94 75 (26.89) 101 (88.60) 6 (85.71) 0.69
Clinical stage
I 48 39 (13.59) 9 (9.47) 0 14.24 37 (13.26) 11 (9.65) 0 11.53
II 147 104 (36.23) 41(43.16) 2 (11.11) 0.025 103 (36.92) 43 (37.72) 1 (14.28) 0.08
III 120 87 (30.31) 26 (27.37) 7 (38.89) 89 (31.90) 28 (24.56) 3 (42.86)
IV 85 57 (19.87) 19 (20.00) 9 (50.00) 50 (17.92) 32 ( 28.07) 3 (42.86)
Tumor localization
Right breast 185 134 (46.69) 43 (45.26) 8 (44.44) 0.841 131 (46.95) 51 (44.74) 3 (42.86) 28.54
Left breast 213 152 (52.96) 51 (53.68) 10 (55.56) 0.93 148 (53.05) 62 (54.39) 3 (42.86) <0.001
Right + Left breast 2 1 (0.35) 1 (1.06) 0 0 1 (0.87) 1 (14.28)

ER, Estrogen Receptor; PR, Progesterone Receptor; Significance p< 0.005